Research Article

Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts

Table 8

Determination of IZD (mm), MIC, and MBC (mg/mL) of C. salviifolius extracts.

StrainsE. faeciumS. aureusK. pneumoniaeA. baumanniiP. aeruginosaE. cloacae
ExtractsIZD mmMIC mg/MlMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MIC

CSM150.211.718160.100.42473.4313.75480.853.43490.053.436481.7113.758
CSS130.420.421140.103.433266.876.87160.211.71870.106.876463.436.872
F1SM103.436.872120.010.856586.8713.75273.436.87280.8513.751696.876.871
F1SS100.421.714120.103.433286.8713.75263.436.87270.0513.7525983.4313.754
F2SM131.876.874140.010.211693.4327.5881.713.43281.716.87493.4313.754
F2SS113.436.872120.856.878713.7513.75163.433.43173.4313.75473.4327.58
F3SM140.420.852140.010.054120.426.8716123.433.431131.713.432123.436.872
F3SS120.210.211120.103.433293.436.87261.711.711133.433.43196.8713.752
F4SM140.420.852150.010.2116100.426.8716120.853.434130.056.87129106.8713.752
F4SS111.713.432120.266.872686.876.87161.713.43293.4313.75476.8727.54
F5SM150.851.712160.050.214113.436.872131.716.874150.026.87264106.8713.752
F5SS116.876.871123.4313.75486.876.87161.711.711123.4313.75476.8727.52

CCSM: crude CS from maceration; CCSS: crude CS from Soxhlet; F1CSM: hexane fraction of CS from maceration; F1CSS: hexane fraction of CS from Soxhlet; F2CSM: dichloromethane fraction of CS from maceration; F2CSS: dichloromethane fraction of CS from Soxhlet; F3CSM: ethyl acetate fraction of CS from maceration; F3CSS: ethyl acetate fraction of CS from Soxhlet; F4CSM: n-butanol fraction of CS from maceration; F4CSS: n-butanol fraction of CS from Soxhlet; F5CSM: remaining aqueous fraction of CS from maceration; and F5CSS: remaining aqueous fraction of CS from Soxhlet.